Health Care & Life Sciences » Pharmaceuticals | Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc. | Ownership

Companies that own Cipher Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Grandeur Peak Global Advisors LLC
1,522,200
5.7%
-32,000
0.12%
04/30/2018
Taylor Asset Management, Inc. (Canada)
243,100
0.91%
0
0.13%
06/30/2017
SEI Investments Canada Co.
186,886
0.7%
0
0.03%
12/31/2017
Beutel, Goodman & Co. Ltd.
130,856
0.49%
0
0%
12/31/2017
1832 Asset Management LP
20,597
0.08%
-94
0%
12/31/2017
Acadian Asset Management LLC
9,093
0.03%
0
0%
06/30/2018
Norrep Capital Management Ltd.
0
0%
-22,700
0%
04/30/2018
Montrusco Bolton Investments, Inc.
0
0%
-472,670
0%
03/31/2018

About Cipher Pharmaceuticals

View Profile
Address
209 Oak Park Boulevard
Oakville Ontario L6H 0M2
Canada
Employees -
Website http://www.cipherpharma.com
Updated 07/08/2019
Cipher Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the robust and diversified portfolio of commercial and late-stage products. It also acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Its products include Actikerall, Aclaro, Beteflam, Epuris, Vaniqa, Dermadexin, Pruridexin, Ozenoxacin, Lipofen, Conzip, and Durela.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.